EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?

Supawadee Suppadungsuk, Kianoush Kashani iD

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvae010 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Supawadee Suppadungsuk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Demyelinating Diseases, Hyponatremia, Sodium. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Demyelinating DiseasesHyponatremiaSodiumHumansSyndrome

Substanzen

Sodium

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.

ORCID-Profile: Kianoush Kashani

Zitieren

APA

Suppadungsuk, S., & Kashani, K. (2024). Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae010

Vancouver

Suppadungsuk S, Kashani K. Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae010

BibTeX
@article{Suppadungsuk2024,
  author = {Suppadungsuk, Supawadee and Kashani, Kianoush},
  title = {Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvae010}
}
Kostenlos starten →